AVI-4065

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVI-4065, covering 2008-04-10 to 2009-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid [Phase 1]